Department of Pediatric General and Urogenital Surgery, Juntendo University School of Medicine, 2- 1-1 Hongo, Bunkyo-ku, Tokyo, 113-8421, Japan.
Department of Research and Development for Organoids, Juntendo University Graduate School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo, 113-8421, Japan.
BMC Urol. 2023 Oct 24;23(1):169. doi: 10.1186/s12894-023-01338-y.
Dysregulation of the terminal differentiation of bladder urothelium is associated with the pathogenesis of urinary tract disorders. Fibroblast growth factor (Fgf)7 and Fgf10 stimulate urothelial proliferation; however, their roles in cellular differentiation remain unclear. In this study, we used an organoid system to investigate the roles of these Fgfs in regulating bladder urothelium differentiation and identify their distribution patterns in the mouse bladder.
Adult bladder epithelia (AdBE) isolated from adult mouse bladder tissues (AdBTs) were used to culture adult bladder organoids (AdBOs) in the presence of Fgf7 and Fgf10. The differentiation status of the cells in AdBTs, AdBEs, AdBOs, and neonatal bladder tissues (NeoBTs) was analyzed via quantitative real-time-PCR for the presence of undifferentiated cell markers (Krt5, Trp63, and Krt14) and differentiated cell markers (Krt20, Upk1a, Upk2, and Upk3a). Organoid cell proliferation was assessed by counting cell numbers using the trypan blue method. The effects of Fgf7 and Fgf10 on organoid differentiation were assessed using different doses of Fgfs, and the involvement of peroxisome proliferator-activated receptor γ (PPARγ) signaling in these processes was tested by introducing a PPARγ agonist (Rosiglitazone) and antagonist (T0070907) to the culture. The expression patterns of Fgf7 and Fgf10 were examined via in situ hybridization of AdBTs.
AdBOs showed higher expression of undifferentiated cell markers and lower expression of differentiated cell markers than AdBTs, NeoBTs, and AdBEs, indicating the relatively immature state of AdBOs. Differentiation of AdBOs was enhanced by Rosiglitazone and Fgf7, suggesting an interplay of intracellular signals between Fgf7 and PPARγ. Co-addition of T0070907 suppressed Fgf7-mediated differentiation, demonstrating that PPARγ is activated downstream of Fgf7 to promote cellular differentiation into umbrella cells. Furthermore, we found that Fgf7 is predominantly expressed in the umbrella cells of the urothelium, whereas Fgf10 is predominantly expressed in the urothelium and stroma of AdBTs.
We demonstrated that unlike Fgf10, Fgf7 induces cellular differentiation via PPARγ activity and has a unique tissue distribution pattern in the adult bladder. Further studies on the Fgf7-PPARγ signaling axis would provide insights into the differentiation mechanisms toward functional umbrella cells and the pathogenesis of several urinary tract diseases.
膀胱尿路上皮的终末分化失调与尿路疾病的发病机制有关。成纤维细胞生长因子(Fgf)7 和 Fgf10 刺激尿路上皮增殖;然而,它们在细胞分化中的作用仍不清楚。在这项研究中,我们使用类器官系统来研究这些 Fgfs 在调节膀胱尿路上皮分化中的作用,并确定它们在小鼠膀胱中的分布模式。
从成年小鼠膀胱组织(AdBTs)中分离的成年膀胱上皮(AdBE)用于在存在 Fgf7 和 Fgf10 的情况下培养成年膀胱类器官(AdBO)。通过定量实时 PCR 分析 AdBTs、AdBEs、AdBOs 和新生膀胱组织(NeoBTs)中未分化细胞标记物(Krt5、Trp63 和 Krt14)和分化细胞标记物(Krt20、Upk1a、Upk2 和 Upk3a)的存在情况来分析细胞的分化状态。通过使用台盼蓝法计数细胞数量来评估类器官细胞的增殖。通过使用不同剂量的 Fgfs 评估 Fgf7 和 Fgf10 对类器官分化的影响,并通过向培养物中引入过氧化物酶体增殖物激活受体 γ(PPARγ)激动剂(罗格列酮)和拮抗剂(T0070907)来测试这些过程中 PPARγ 信号的参与。通过 AdBTs 的原位杂交检查 Fgf7 和 Fgf10 的表达模式。
与 AdBTs、NeoBTs 和 AdBEs 相比,AdBO 表现出更高的未分化细胞标记物表达和更低的分化细胞标记物表达,表明 AdBO 相对不成熟。罗格列酮和 Fgf7 增强了 AdBO 的分化,表明 Fgf7 和 PPARγ 之间存在细胞内信号相互作用。共同添加 T0070907 抑制了 Fgf7 介导的分化,表明 PPARγ 被激活为 Fgf7 的下游以促进细胞向伞细胞分化。此外,我们发现 Fgf7 主要在尿路上皮的伞细胞中表达,而 Fgf10 主要在 AdBTs 的尿路上皮和基质中表达。
我们证明,与 Fgf10 不同,Fgf7 通过 PPARγ 活性诱导细胞分化,并在成年膀胱中具有独特的组织分布模式。对 Fgf7-PPARγ 信号轴的进一步研究将为功能性伞细胞的分化机制和几种尿路疾病的发病机制提供深入了解。